Indirect comparison between immune checkpoint inhibitors and targeted therapies for the treatment of melanoma.

J Cancer · 2019 · PMC6856565 · PMID 31762821

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Third, some of the evidence supporting survival priority was based on marginally significant advantage as the confidence interval cross the null value.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.